Japan-based Maruho Co Ltd has named Atsushi Sugita as its new president and chief executive officer, effective 18 December 2020, it was reported on Friday.
Sugita is to replace Koichi Takagi who will remain with the company as chairman of the board.
Sugita has served at Johnson & Johnson's US headquarters and Janssen Japan. He held various positions at Maruho's R&D Labs, Head Office, and global subsidiaries.
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient